System and method of obtaining and using a vehicle identifier for providing information to an end user

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Ehud Mendelson patent solves the following problem:

The scope of this innovation:

Our analysis of this patent is as follows:

Ehud Mendelson’s patent US 8941485 B1 deals with System and method of obtaining and using a vehicle identifier for providing information to an end user.
A proper navigation system in use in a fleet to deploy RF lights and an associated application. The RF-lights installed in known locations on a predefined area facilities. The RF lights emit a Bluetooth or Wi-Fi signal light. An RF light signal encoded into the signal light. The location of the light is determined by using the light identifier with an index light place. The site can be used to determine a place to receive mobile device, when the vehicle information associated with the merchants in mangrove areas, assistance for parking, and other systems can be used to help in case of emergency, – acquisition of road sign information, and other applications where RF beacon can transmit specific location based services and information.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Human anti-alpha-synuclein antibodies

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Biogen Idec International Neuroscience Gmbh, , University Of Zurich patent solves the following problem:

Protein misfolding and aggregation of pathological features of many neurodegenerative diseases. Aggregates -synuclein major component of Lewy bodies and Lewy neurites associated with Parkinson's disease (PD). A natively expressed proteins, -synuclein may adopt different aggregated morphologies, including oligomers, Protofibrils and fibrils. The small oligomeric aggregates shown especially toxic.

Our analysis of this patent is as follows:

Biogen Idec International Neuroscience Gmbh, , University Of Zurich’s patent US 8940276 B2 deals with Human anti-alpha-synuclein antibodies.
If the human alpha-synuclein-specific autoantibodies as well as fragments, derivatives and race as well as the procedures associated with them. Curiosity, kits, and strong columns related to the antibody specific for -synuclein also revealed. The antibody, immunoglobulin (s) chain, as well as binding fragments, derivatives and its use in pharmaceutical and diagnostic compositions for -synuclein target immunotherapy and diagnosis, respectively.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Device for a membrane assay

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Denko Seiken Co., Ltd. patent solves the following problem:

In recent years, simple test reagents or kits to make a kind of trial as the presence of pathogen infection such as a virus or bacteria, or pregnancy developed. Detection or quantification of a pathogen component or hormone is the subject of this trial. Many of these simple reagents test is inexpensive, simple to operate and does not require specific equipment or devices.

Our analysis of this patent is as follows:

Denko Seiken Co., Ltd.’s patent US 8940525 B2 deals with Device for a membrane assay.
Disclosed is a simple device for a membrane assay using lateral flow ImmunoAssay way, where a subject detected in a high feeling, which, as a label drying pad , a substrate that has a higher tensile strength than glass fiber and the release of a label. The present invention provides a simple membrane assay device, comprising: a support frame, and a portion of the sample supply, a label containing a labeling component called a subject notice, a development part formed in a detection portion includes a trapping reagent recognition or quantifying the subject observed, and an absorption part, which is a non-woven cloth included the fibers with a fiber diameter of 0.05 to 10 m used in the labeling component part.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Vegenics Pty Limited patent solves the following problem:

The cellular behavior responsible for the development, maintenance and repair to the difference between cells and tissues that are regulated, in large part, by intercellular signals conveyed by growth factors and similar ligands and their receptor. The receptor located on the cell surface of responding cells and they bind peptides or polypeptides known as growth factors as well as other hormone-like ligands. The results of the partnership this rapid biochemical changes in the responding cells, as well as a rapid and a long-term readjustment of cellular gene expression. Some receptor associated with various surfaces cell bind to certain things to grow.

Our analysis of this patent is as follows:

Vegenics Pty Limited’s patent US 8940695 B2 deals with Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy.
The present invention to provide pure Flt4 receptor tyrosine kinase polypeptides and fragments thereof, polynucleotides encoding such polypeptides, antibodies that specifically bind the polypeptides, and uses thereof.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Diagnosis of autism spectrum disorders and its treatment with an antagonist or inhibitor of the 5-HT2c receptor signaling pathway

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Massachusetts Institute Of Technology patent solves the following problem:

Autism spectrum disorder (ASD) is highly heritable, with a 2-3% return rate in brothers and a 60-90% concordance rate in monozygotic twins. However, known genetic causesfor example, a gene disorder as attractive-X or tuberous sclerosis, or chromosomal abnormalitiesaccount for approximately 10% of ASD cases. Therefore, the majority of cases of ASD unknown causes at present. Current estimates of the ASD susceptibility to deliver several genes interacting with one another, as well as with environmental factors.

Our analysis of this patent is as follows:

Massachusetts Institute Of Technology’s patent US 8940732 B2 deals with Diagnosis of autism spectrum disorders and its treatment with an antagonist or inhibitor of the 5-HT2c receptor signaling pathway.
The invention relates to methods for the diagnosis and treatment of autism spectrum disorder, especially for autism spectrum disorder characterized by increased volume in the head (circumference) and deficits in social behavior.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Anti-fXI antibodies and methods of use

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Oregon Health & Science University, , Vanderbilt University patent solves the following problem:

Thrombosis is a general term for diseases caused by localized accumulation of rotating elements of blood within the vasculature leading to vessel occlusion. Conventional antithrombotic drugs can inhibit thrombus growth through targeted way coagulation (for example, heparin and warfarin) or platelet-dependent mechanism (such as aspirin or clopidogrel). Thrombolytic agents (eg, Streptokinase) used to degrade thrombi in situ to restore blood flow. Despite the progress in this field, to search for new ways to continue because current treatments prevent hemostasis, and should be administered in doses that achieve the maximum effectiveness (Gruber Hanson, Curr Pharm Des 9 (28): 2367-2374, 2003).

Our analysis of this patent is as follows:

Oregon Health & Science University, , Vanderbilt University’s patent US 8940883 B2 deals with Anti-fXI antibodies and methods of use.
Said here is the monoclonal antibody specific for things XI (FXI) which prevent the activation of FXI by something Xiia (fXIIa). The monoclonal antibody universal FXI antibody, can bind all mammal species tested. The anti-FXI monoclonal antibody prolonged clotting time in the mammal plasmas. Furthermore, administration of FXI monoclonal antibody revealed results in the inhibition of thrombosis without modification hemostasis in animal models of thrombosis. Thus, given this is a monoclonal antibody specific for FXI to block activation of FXI fXIIa, composition and immunoconjugates comprising the antibody and their methods of use.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Human monoclonal antibody

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Sumitomo Dainippon Pharma Co., Ltd. patent solves the following problem:

Heart mind and organs absorb nutrients and water essential for life to organisms. Meanwhile, they are also organs of a immunodefense performance about foreign things like pathogens and keep life conservation by controlling contradictory qualities in a well-balanced way . But it is known that when the balance of these functions become abnormal, this dynamic equilibrium is broken to induce various diseases intestines. Especially, inflammatory bowel disease (abbreviated as IBD), patients have increased the number in recent years, associated with disorders of the digestive organs such as stomach pain, diarrhea, mucous and bloody stool and the like and, in view of pathogenic states thereof, grouped into ulcerative colitis and Crohn's disease.

Our analysis of this patent is as follows:

Sumitomo Dainippon Pharma Co., Ltd.’s patent US 8940710 B2 deals with Human monoclonal antibody.
The present invention provides an anti-CD81 antibody used as a pharmaceutical product for men. In particular, the present invention provides an anti-human CD81 antibody can bind to a peptide region containing the amino acid at amino acid number 80 to 175 in the amino acid is shown in SEQ ID NO : 22.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Lithographic apparatus and device manufacturing method

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Asml Netherlands B.V. patent solves the following problem:

A lithographic apparatus is a machine that applies a desired pattern onto a substrate, usually onto a target portion of the substrate. A lithographic apparatus can be used, for example, in the manufacture of integrated circuits (ICs). In time, a pattern maker, alternatively referred to as a mask or a reticle, can be used to generate a circuit pattern formed on an individual layer of the IC. This pattern can be transferred to a target segment (comprised of, one, or several dies) on a substrate (eg a silicon wafer). Transfer the pattern is usually by imaging onto a layer of radiation-sensitive material (resist) provided on the substrate. In general, a substrate consisting of a network of adjacent target portions that order followed. Known lithographic apparatus include so-called steppers, each target portion irradiated by exposing an entire pattern onto the target at a time, and so-called scanners, each target portion irradiated with scanning the pattern through a radiation beam in one direction (the scanning direction) while synchronously scanning the substrate parallel or anti-parallel to this direction. It is also possible to transfer the pattern from the following devices to the substrate by imprinting the pattern to the substrate.

Our analysis of this patent is as follows:

Asml Netherlands B.V.’s patent US 8941810 B2 deals with Lithographic apparatus and device manufacturing method.
A lithograph facilities in a cover plate formed separately from a substrate table and means to strengthen a temperature substrate table by controlling the temperature of the cover plate revealed. A lithograph device thermal insulation provided between a cover plate and a substrate table so that the cover plate acts as a heat shield for the substrate table revealed. A lithographic apparatus comprising means for determining a substrate table corruption and to improve the position control to a substrate by reference to the substrate table distortion is disclosed.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Optical characterization systems employing compact synchrotron radiation sources

File for Quick & Easy Patent Protection with PowerPatent.

The Kla-Tencor Corporation patent solves the following problem:

Plasma based light sources are often implemented to generate extreme ultraviolet (EUV) and vacuum ultraviolet (VUV) light in wafer and mask inspection systems. For example, discharged plasma (DPP) and laser-made plasma (LPP) conventional components of EUV light source technology.

Our analysis of this patent is as follows:

Kla-Tencor Corporation’s patent US 8941336 B1 deals with Optical characterization systems employing compact synchrotron radiation sources.
A compact synchrotron radiation source includes an electron beam generator, an electron storage ring, one or more wiggler insertion device thrown by one or more straight sections of electrons the storage ring, one or more wiggler insertion devices including a set of magnetic pole configured to generate a periodic alternating magnetic field suitable for the production of synchrotron radiation emitted by the direction of travel the electrons in the storage ring, where one or more wiggler insertion devices are arranged to provide light to a bundle of light optics in a wafer optical characterization system or a mask optical characterization system, which étendue a light beam emitted by one or more wiggler device insertion met in light optics at least one of a wafer optical characterization system the mask optical characterization system.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Low loop wire bonding

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Carsem (M) Sdn, Bhd. patent solves the following problem:

The present invention relates in general to semiconductor packaging and, especially, the wire bonding between the contact position substantially the same length or in a semiconductor package.

Our analysis of this patent is as follows:

Carsem (M) Sdn, Bhd.’s patent US 8941249 B2 deals with Low loop wire bonding.
A multi-die package includes a first semiconductor die and a second semiconductor die each having an upper surface with a plurality of bond pads positioned thereon. The multi-die package also includes a plurality of wire ties each coupling one of the bond pads on the surface of the first semiconductor die to a corresponding one of the bond pads on the surface of the second the semiconductor die. A wire ties in polygamous relationships wire includes a first portion extending upward from one of the second plurality of bond pads substantially along a z-axis and the curving but the largest by x and y axes in a direction toward the first semiconductor die. The bonding wire also includes a second part with the first part and extending from the first side of the one of the first plurality of bond pads on the surface of the first semiconductor die.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.